The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2019 | The evolving role of the nurse in cancer therapy
Here, Celia Diez de los Rios, ANP, from the University of Southampton NHS Foundation Trust, Southampton, UK, discusses the impact of novel cancer therapies on the role of nurses. Speaking at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland, Ms de los Rios explains how the introduction of new immunotherapies in particular has led to changes in treatment duration, side effects observed, and the challenges faced.
